Methyl 2-bromohexanoate | CAS:5445-19-2

We serve Methyl 2-bromohexanoate CAS:5445-19-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Methyl 2-bromohexanoate

Chemical Name:Methyl 2-bromohexanoate
CAS.NO:5445-19-2
Synonyms:Methyl 2-bromohexanoate
Molecular Formula:C7H13BrO2
Molecular Weight:209.08100
 
Physical and Chemical Properties:
Density:1.289;
Melting point:-10oC;
Boiling point:195.9oC;
Flash point:80.6oC;
Index of Refraction:1.455;
 
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥99.0%
Moisture:≤0.1%
pH:6.0-8.0
 
Packing:250 kg/drum, can also be packaged according to customer requirements
Synthesis:The product is obtained by esterification of 2-bromohexanoic acid and methanol
Application:As an intermediate in organic synthesis



Contact us for information like Methyl 2-bromohexanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 2-bromohexanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 2-bromohexanoate Use and application,Methyl 2-bromohexanoate technical grade,usp/ep/jp grade.


Related News: The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid manufacturer The best you can do is take medicines and treatments for specific symptoms.1-[(2R,4S,5S)-4-azido-5-(trityloxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione supplier From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.1,2-Diethoxybenzene vendor From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.Australia has started denying entry to all travelers who have come from or transited through mainland China.